With a rare cancer like mesothelioma, it’s not always easy to conduct clinical trials, but the National Cancer Institute has opened two new ones involving promising immunotoxins.
Related Post:
New Drug Therapy May Improve Mesothelioma Survival Rate
The results of a study performed by the National Institute of Cancerologia in Mexico City may raise new hopes for patients diagnosed with the asbestos-related ...
Mesothelioma Developments Underway Despite Loss of Funding
The search for a mesothelioma cure is still underway, and a number of medical researchers are dedicating their time to extensive clinical and laboratory tests ...
Mesothelioma Patients’ Post-Surgery Prognosis Predicted by Gene Expression Ratio Test
Researchers from the Brigham and Women’s Hospital completed a study of a four-gene expression ratio test that potentially differentiated mesothelioma patients with a statistically longer ...
Action Mesothelioma Day Recognizes Rare Cancer
For those living in the United Kingdom, today marks Action Mesothelioma Day, an attempt to spread awareness about a rare cancer caused by asbestos exposure. ...
Doctor and Author of Leading Mesothelioma Textbook Joins Comprehensive Cancer Centers of Nevada
Renowned cancer researcher Dr. Nicholas J. Vogelzang has joined the United States Oncology Research network where he will serve as the Medical Director and chair ...
Tags: Asbestos, asbestos cancer articles, Clinical Trials, lung cancer, mesothelioma, mesothelioma and asbestos cancer, mesothelioma articles, mesothelioma cancer, research, treatment